Tutuş A, Erkiliç K, Ercan M T, Kontaş O, Aydin M, Doğan H
Department of Nuclear Medicine, Faculty of Medicine, Erciyes University, Kayseri, Turkey.
Ann Nucl Med. 1997 May;11(2):143-6. doi: 10.1007/BF03164823.
In a patient with ocular melanoma scintigraphy obtained with 99mTc-GSH clearly demonstrated the histologically proven ocular lesion both in planar and SPECT images. 99mTc-sestamibi study obtained in the same patient three days later was negative. 99mTc-GSH is a potential alternative to the currently used radiopharmaceuticals for imaging both cutaneous and ocular melanomas and their metastases.
在一名眼黑色素瘤患者中,用99mTc-GSH进行的闪烁扫描在平面和SPECT图像中均清晰显示了经组织学证实的眼部病变。三天后在同一患者身上进行的99mTc-甲氧基异丁基异腈研究结果为阴性。99mTc-GSH是目前用于皮肤和眼黑色素瘤及其转移灶成像的放射性药物的一种潜在替代品。